Skip to main content

Advertisement

SpringerLink
Log in

Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case–control study

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The objective of this study is to examine the association between vitamin D status and risk of breast cancer in an Australian population of women. The study design is observational case–control study, performed at Westmead Breast Cancer Institute, Westmead Hospital, Sydney, Australia. 214 women newly diagnosed with breast cancer were matched to 852 controls, and their blood samples were tested at the same laboratory between August 2008 and July 2010. Circulating 25-hydroxyvitamin D (25(OH)D) concentration, was defined as sufficient (≥75 nmol/L), insufficient (50–74 nmol/L), deficient (25–49 nmol/L) or severely deficient (<25 nmol/L). The difference in median 25(OH)D concentration between cases and controls was reported, and the Mann–Whitney U test was used to determine the significance of the difference. Odds ratios and 95 % confidence intervals for the risk of breast cancer were estimated by Cox regression. Median plasma 25(OH)D was significantly lower in cases versus controls overall (53.0 vs 62.0 nmol/L, P < 0.001) and during summer (53.0 vs 68.0 nmol/L, P < 0.001) and winter (54.5 vs 63.0 nmol/L, P < 0.001). Median 25(OH)D was also lower in cases when stratified by BMI (<30, ≥30) and age group (<50, ≥50 years) compared to matched controls, although the difference failed to reach statistical significance. In a Cox regression model, plasma 25(OH)D was inversely associated with the odds ratio of breast cancer. Compared to subjects with sufficient 25(OH)D concentration, the odds ratios of breast cancer were 2.3 (95 % CI 1.3–4.3), 2.5 (95 % CI 1.6–3.9) and 2.5 (95 % CI 1.6–3.8) for subjects categorised as severely deficient, deficient or insufficient vitamin D status, respectively. The results of this observational case–control study indicate that a 25(OH)D concentration below 75 nmol/L at diagnosis was associated with a significantly higher risk of breast cancer. These results support previous research which has shown that lower 25(OH)D concentrations are associated with increased risk of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Holick MF (2008) Vitamin D: a D-lightful health perspective. Nutr Rev 66(10 Suppl 2):S182–S194

    Article  PubMed  Google Scholar 

  2. Zerwekh JE (2008) Blood biomarkers of vitamin D status. Am J Clin Nutr 87(4):1087S–11091

    PubMed  CAS  Google Scholar 

  3. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Nutrition Board IoM (1997) Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride. National Academy of Sciences, Washington

  4. Bikle D (2009) Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94(1):26–34

    Article  PubMed  CAS  Google Scholar 

  5. Mohr SB, Garland CF, Gorham ED, Grant WB, Garland FC (2008) Relationship between low ultraviolet B irradiance and higher breast cancer risk in 107 countries. Breast J 14(3):255–260

    Article  PubMed  Google Scholar 

  6. Gorham ED, Garland FC, Garland CF (1990) Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 19(4):820–824

    Article  PubMed  CAS  Google Scholar 

  7. Rejnmark L, Tietze A, Vestergaard P, Buhl L, Lehbrink M, Heickendorff L, Mosekilde L (2009) Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 18(10):2655–2660. doi:10.1158/1055-9965.EPI-09-0531

    Article  PubMed  CAS  Google Scholar 

  8. Bertone-Johnson ER, Chen WY, Holick MF, Hollis BW, Colditz GA, Willett WC, Hankinson SE (2005) Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 14(8):1991–1997

    Article  PubMed  CAS  Google Scholar 

  9. Eliassen AH, Spiegelman D, Hollis B, Horst R, Willett W, Hankinson S (2011) Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses’ Health Study II. Breast Cancer Res 13(3):R50

    Article  PubMed  Google Scholar 

  10. Freedman DM, Chang SC, Falk RT, Purdue MP, Huang WY, McCarty CA, Hollis BW, Graubard BI, Berg CD, Ziegler RG (2008) Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev 17(4):889–894

    Article  PubMed  CAS  Google Scholar 

  11. McCullough ML, Stevens VL, Patel R, Jacobs EJ, Bain EB, Horst RL, Gapstur SM, Thun MJ, Calle EE (2009) Serum 25-hydroxyvitamin D concentrations and postmenopausal breast cancer risk: a nested case control study in the Cancer Prevention Study-II Nutrition Cohort. Breast cancer research 11(4):R64. doi:10.1186/bcr2356

    Article  PubMed  Google Scholar 

  12. Freedman DM, Looker AC, Chang SC, Graubard BI (2007) Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 99(21):1594–1602

    Article  PubMed  CAS  Google Scholar 

  13. Garland FC, Garland CF, Gorham ED, Young JF (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19(6):614–622

    Article  PubMed  CAS  Google Scholar 

  14. Chen W, Clements M, Rahman B, Zhang S, Qiao Y, Armstrong BK (2010) Relationship between cancer mortality/incidence and ambient ultraviolet B irradiance in China. Cancer Causes Control 21(10):1701–1709. doi:10.1007/s10552-010-9599-1

    Article  PubMed  Google Scholar 

  15. Engel P, Fagherazzi G, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F (2011) Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N cohort. Cancer Epidemiol Biomarkers Prev 20(1):187–198

    Article  PubMed  CAS  Google Scholar 

  16. Medicine IIo (2011) Dietary reference intakes for calcium and vitamin D. The National Academies, Washington

    Google Scholar 

  17. Grant WB (2011) Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinology 3(3):199–204. doi:10.4161/derm.3.3.15364

    CAS  Google Scholar 

  18. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, wson-Hughes B (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84(1):18–28

    PubMed  CAS  Google Scholar 

  19. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16(7):713–716

    Article  PubMed  CAS  Google Scholar 

  20. Heaney RP (2008) Optimal Vitamin D Status. J Bone Miner Res 24(4):755

    Article  Google Scholar 

  21. Vieth R (2006) What is the optimal vitamin D status for health? Prog Biophys Mol Biol 92(1):26–32

    Article  PubMed  CAS  Google Scholar 

  22. Engel P, Fagherazzi G, Boutten A, Dupre T, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F (2010) Serum 25(OH) vitamin D and risk of breast cancer: a nested case-control study from the French E3N cohort. Cancer Epidemiol Biomarkers Prev 19(9):2341–2350

    Article  PubMed  CAS  Google Scholar 

  23. John EM, Schwartz GG, Dreon DM, Koo J (1999) Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971–1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 8(5):399–406

    Google Scholar 

  24. Bolland MJ, Grey A, Gamble GD, Reid IR (2011) Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women’s Health Initiative (WHI) limited-access data set. Am J Clin Nutr. doi:10.3945/ajcn.111.015032

  25. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H (2010) Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer 46(12):2196–2205. doi:S0959-8049(10)00280-7

    Article  PubMed  CAS  Google Scholar 

  26. Almquist M, Bondeson AG, Bondeson L, Malm J, Manjer J (2010) Serum levels of vitamin D, PTH, calcium and breast cancer risk: a prospective nested case-control study. Int J Cancer 127(9):2159–2168

    Article  PubMed  CAS  Google Scholar 

  27. Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O’Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA (2008) Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 100(22):1581–1591

    Article  PubMed  CAS  Google Scholar 

  28. Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, Dworakowski E, Shane E, Terry MB, Desai M, Teitelbaum SL, Neugut AI, Santella RM (2009) Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila) 2(6):598–604

    Article  CAS  Google Scholar 

  29. Colston KW, Lowe LC, Mansi JL, Campbell MJ (2006) Vitamin D status and breast cancer risk. Anticancer Res 26 (4A):2573–2580

    Google Scholar 

  30. Abbas S, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, Flesch-Janys D, Chang-Claude J (2008) Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer–results of a large case-control study. Carcinogenesis 29(1):93–99

    Article  PubMed  CAS  Google Scholar 

  31. Abbas S, Chang-Claude J, Linseisen J (2009) Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case–control study. Int J Cancer 124(1):250–255

    Article  PubMed  CAS  Google Scholar 

  32. Lowe LC, Guy M, Mansi JL, Peckitt C, Bliss J, Wilson RG, Colston KW (2005) Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 41(8):1164–1169

    Article  PubMed  CAS  Google Scholar 

  33. Fedirko V, Torres-Mejia G, Ortega-Olvera C, Biessy C, Angeles-Llerenas A, Lazcano-Ponce E, Saldana-Quiroz VA, Romieu I (2012) Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women. Cancer Causes Control 23(7):1149–1162. doi:10.1007/s10552-012-9984-z

    Article  PubMed  Google Scholar 

  34. Abbas S, Linseisen J, Chang-Claude J (2007) Dietary vitamin D and calcium intake and premenopausal breast cancer risk in a German case–control study. Nutr Cancer 59(1):54–61

    Article  PubMed  CAS  Google Scholar 

  35. Knight JA, Lesosky M, Barnett H, Raboud JM, Vieth R (2007) Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 16(3):422–429

    Article  PubMed  CAS  Google Scholar 

  36. Grant W (2012) Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyitamin D and all-cause mortality rate. Dermatoendocrinology 4(2):198–202

    Article  CAS  Google Scholar 

  37. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72(3):690–693

    PubMed  CAS  Google Scholar 

  38. Harvie M, Hooper L, Howell AH (2003) Central obesity and breast cancer risk: a systematic review. Obes Rev 4(3):157–173

    Article  PubMed  CAS  Google Scholar 

  39. Amir E, Cecchini RS, Ganz PA, Costantino JP, Beddows S, Hood N, Goodwin PJ (2012) 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1. Breast Cancer Res Treat 133(3):1077–1088. doi:10.1007/s10549-012-2012-x

    Article  PubMed  CAS  Google Scholar 

  40. Boyages SB, Bilinski K (2012) Seasonal variation in vitamin D persists into spring: Implications for monitoring and replacement therapy. Clin Endocrinol (Oxf.) 77(4):515–523

    Google Scholar 

  41. Daly RM, Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Sikaris KA, Zimmet PZ, Ebeling PR, Shaw JE (2011) Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin Endocrinol. doi:10.1111/j.1365-2265.2011.04320.x

    Google Scholar 

  42. Pink B (2006) Information paper: an introduction to Socio-Economic Indexes for Areas (SEIFA). Australian Bureau of Statistics, Canberra

    Google Scholar 

  43. Bischoff-Ferrari HA (2008) Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol 624:55–71

    Article  PubMed  CAS  Google Scholar 

  44. Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135(2):317–322

    PubMed  CAS  Google Scholar 

  45. Centre NBaOC (2009) Breast cancer risk factors a review of the evidence. National Breast and Ovarian Cancer Centre, Surry Hills SNW 2010

  46. WHO (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. WHO Technical Report Series 894. WHO, Geneva

  47. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N (2009) Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27(23):3757–3763

    Article  PubMed  CAS  Google Scholar 

  48. Peppone L, Rickles A, Huston A, Sprod L, Hicks D, Mustian K, Skinner K (2011) The association between prognostic demographic and tumor characteristics of breast carcinomas with serum 25-OH vitamin D levels. Cancer Epidemiol Biomarks Prev 20(4):717

    Article  Google Scholar 

  49. Colston KW (2008) Vitamin D and breast cancer risk. Best Pract Res Clin Endocrinol Metab 22(4):587–599

    Article  PubMed  CAS  Google Scholar 

  50. Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC (2002) Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst 94(17):1301–1311

    Article  PubMed  CAS  Google Scholar 

  51. Lin J, Manson JE, Lee IM, Cook NR, Buring JE, Zhang SM (2007) Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med 167(10):1050–1059

    Article  PubMed  CAS  Google Scholar 

  52. Lagunova Z, Porojnicu AC, Grant WB, Bruland ò, Moan JE (2010) Obesity and increased risk of cancer: does decrease of serum 25-hydroxyvitamin D level with increasing body mass index explain some of the association? Mol Nutr Food Res 54(8):1127–1133

    PubMed  CAS  Google Scholar 

  53. Platz EA, Leitzmann MF, Hollis BW, Willett WC, Giovannucci E (2004) Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control 15(3):255–265. doi:10.1023/B:CACO.0000024245.24880.8a

    Article  PubMed  Google Scholar 

  54. Heijboer AC, Blankenstein MA, Kema IP, Buijs MM (2012) Accuracy of 6 routine 25-hydroxyvitamin d assays: influence of vitamin D binding protein concentration. Clin Chem 58(3):543–548. doi:10.1373/clinchem.2011.176545

    Article  PubMed  CAS  Google Scholar 

  55. Lai JK, Lucas RM, Banks E, Ponsonby AL (2012) Variability in vitamin D assays impairs clinical assessment of vitamin D status. Intern Med J 42(1):43–50. doi:10.1111/j.1445-5994.2011.02471.x

    Article  PubMed  CAS  Google Scholar 

  56. Hill A (1965) The environment and disease: association or causation? Proc R Soc Med 58:295–300

    PubMed  CAS  Google Scholar 

  57. Grant WB (2009) How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer? An examination using Hill’s criteria for causality. Dermatoendocrinology 1(1):17–24

    Article  CAS  Google Scholar 

  58. Mohr SBGE, Alcaraz JE, Kane CI, Macera CA, Parsons JE, Wingard DL, Garland CF (2012) Does the evidence for an inverse relationship between serum vitamin D status and breast cancer risk satisfy the Hill criteria? Dermatoendocrinology 4(2):152–157

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank Gary Ma from the ICPMR for providing the data used for matching and Olivia Wroth for editing this manuscript.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Westmead Breast Cancer Institute, Westmead Hospital, PO Box 143, Westmead, NSW, 2145, Australia

    K. Bilinski

  2. Macquarie University Cancer Institute, Macquarie University Hospital, 2 Technology Place, Sydney, NSW, 2109, Australia

    J. Boyages

Authors
  1. K. Bilinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Boyages
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Bilinski.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bilinski, K., Boyages, J. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case–control study. Breast Cancer Res Treat 137, 599–607 (2013). https://doi.org/10.1007/s10549-012-2381-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-012-2381-1

Keywords

Search

Navigation